OR WAIT null SECS
November 16, 2021
Richard Denk, Senior Consultant Aseptic Processing and Containment, SKAN AG, discusses the evolution of aseptic processing with a particular focus on isolators.
November 12, 2021
The Democratic legislative proposal to authorize price negotiations on costly medicines covered by Medicare has drawn opposition from brand pharmaceutical and biotech companies.
November 10, 2021
The agency is evaluating Moderna’s application for use of Spikevax in children aged 6 to 11.
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
November 08, 2021
Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.
November 03, 2021
Investing in formulation strategies earlier on in development will maximize the chance of success.
Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.
November 02, 2021
Best practices help mitigate generic drug shortages.
SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.
October 29, 2021
Novavax has filed its COVID-19 vaccine for authorization in the UK and Australia.